Merck's Keytruda helps lung cancer patients live longer in trial
Go back to Merck's Keytruda helps lung cancer patients live longer in trial| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,179,791 | |||||
| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.01 +1.54 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.47 | 52 Week High | $77.12 | |||
| Open | $65.79 | 52 Week Low | $49.03 | |||
| Day High | $67.55 | P/E | 43.51 | |||
| Day Low | $65.13 | EPS | $1.54 | |||
| Volume | 7,932,248 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 152.55 +3.56 (2.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.99 | 52 Week High | $65.46 | |||
| Open | $149.12 | 52 Week Low | $47.97 | |||
| Day High | $154.49 | P/E | 103.78 | |||
| Day Low | $148.59 | EPS | $1.47 | |||
| Volume | 15,974,897 | |||||
